Republic of Moldova vs Republic of Moldova: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Republic of Moldova
0.3%
in 2024
Republic of Moldova
0.3%
in 2024
Republic of Moldova rank
85th
Republic of Moldova rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Republic of Moldova
- Republic of Moldova
How they compare
Republic of Moldova currently reports 0.3% against 0.3% in Republic of Moldova, a difference of 0.0%.
Across all 10 years both countries report, Republic of Moldova has been ahead every year.
Republic of Moldova ranks 85th and Republic of Moldova ranks 85th of 246 countries.
Head to head by decade
| Decade | Republic of Moldova | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | — |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Republic of Moldova or Republic of Moldova?
- Republic of Moldova, at 0.3% against 0.3% in Republic of Moldova as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Republic of Moldova and Republic of Moldova?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Republic of Moldova?
- 10 years are reported by both, from 2015 to 2024.
- How do Republic of Moldova and Republic of Moldova rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Republic of Moldova ranks 85th and Republic of Moldova ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.